|
MRI News Service:
'Cation' p17 |
|
|
|
 |
 | | | ''For time-resolved acquisitions with k-space undersampling, a simulation method was developed for selecting imaging parameters based on minimization of errors in signal intensity versus time and physiologic parameters derived from tracer kinetic analysis. ...' | | Thursday, 5 November 2009 by www.ncbi.nlm.nih.gov |
|
|
|
| | | ''iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announced financial results for the three and nine months ending September 30, 2009. Financial ...' | | | Wednesday, 28 October 2009 by www.reuters.com | |
|
|
|
| | | ''IF you thought magnets were just useful to hold inane messages on your fridge door, think again. This is magnets: the next generation. Magnets feature in many everyday items - computers, televisions, cars, credit cards - but the use in many ...' | | | Tuesday, 20 October 2009 by www.cambridge-news.co.uk | |
|
|
|
| | | ''Eastern Europe is poised to be the market to tap into in the near future for magnetic resonance imaging (MRI) manufacturers. These countries have budgets allocated to improve their healthcare systems after becoming members of the European Union (EU). ...' | | | Tuesday, 13 October 2009 by in.sys-con.com | |
|
|
|
| | | ''At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Aspect Magnet Technologies and Bruker BioSpin, a division of Bruker Corporation (NASDAQ: BRKR), today announced that they have signed a Memorandum of Understanding (MoU) for the ...' | | | Wednesday, 23 September 2009 by www.businesswire.com | |
|
|
|
| | | ''Rutgers University and two collaborators have received a $3.4 million research grant to develop tools aimed at improving the identification of prostate cancer using MRI, or magnetic resonance imaging. The five-year grant, with funding in the first ...' | | | Tuesday, 22 September 2009 by news.rutgers.edu | |
|
|
|
| | | ''IntroductionAt present, no disease-modifying osteoarthritis drugs (DMOADS) are approved by the FDA (US Food and Drug Administration); possibly partly due to inadequate trial design since efficacy demonstration requires disease progression in the placebo ...' | | | Friday, 24 July 2009 by 7thspace.com | |
|
|
|
| | | ''One of the major issues in the management of prostate cancer is the identification of early physical (as opposed to biochemical) evidence of metastatic disease. For some years now, an imaging agent known as ferumoxtran-10 (Combidex) has been in ...' | | | Wednesday, 17 June 2009 by prostatecancerinfolink.net | |
|
|
|
| | | ''NanoScan Imaging, LLC today announced the publication of new data demonstrating the use of its investigational, radio-opaque contrast agent (N1177) to visualize vulnerable plaques that can cause heart attack or stroke using advanced, non-invasive and ...' | | | Thursday, 11 June 2009 by www.businesswire.com | |
|
|
|
| | | ''Confirma, pioneer of CADstream, a dedicated MRI-CAD system designed to maximize workflow, announced today that it continues to see strong demand for MRI-CAD with the launch of its newest applications earlier this year. The Company's new MRI-CAD ...' | | | Tuesday, 9 June 2009 by www.biospace.com | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
When I took office, only high energy physicists had ever heard of what is
called the Worldwide Web.... Now even my cat has its own page.
-
Bill Clinton |
|
|
News
top
